Position in LLY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$95,656
-$48,351 QoQ
Shares Held
104
-22.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Navigoe, LLC holds $1,002,205 across 11 Drug Manufacturers - General names. LLY ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
2,027 | $713,199 | |
| 2 | ABBV |
AbbVie Inc.
|
512 | $111,354 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
104 | $95,656 | |
| 4 | PFE |
Pfizer Inc
|
880 | $24,710 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
400 | $24,260 | |
| 6 | JNJ |
Johnson & Johnson
|
75 | $18,333 | |
| 7 | MRK |
Merck & Co., Inc.
|
81 | $9,743 | |
| 8 | NVS |
Novartis AG
|
23 | $3,513 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,656 | 104 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $144,007 | 134 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $102,242 | 134 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $78,732 | 101 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $83,416 | 101 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $77,972 | 101 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||